Diffusion-Weighted Imaging infarct volume and neurologic outcomes after ischemic stroke

被引:11
作者
Attye, A. [1 ,2 ]
Boncoeur-Martel, M. -P. [1 ]
Maubon, A. [1 ]
Mounayer, C. [1 ]
Couratier, P. [3 ]
Labrunie, A. [4 ]
Le Bas, J. -F. [5 ]
机构
[1] CHU Limoges, Neuroradiol Radiol Dept, F-87000 Limoges, France
[2] CHU Limoges, Dept Radiol, F-87000 Limoges, France
[3] CHU Limoges, Dept Neurol, F-87000 Limoges, France
[4] CHU Limoges, Clin Res & Biostat Unit, F-87000 Limoges, France
[5] Univ Grenoble 1, CHU Grenoble, Dept Neuroradiol, F-38043 Grenoble 9, France
关键词
Cerebral ischemia; Diffusion-Weighted Imaging lesion volume; Stroke outcome; Prognosis; LESION VOLUME; PREDICTION; TRIAL; RECOVERY; SCALE; TIME;
D O I
10.1016/j.neurad.2012.01.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: This study's purpose was to demonstrate a relationship between growth of stroke volume measured on Diffusion-Weighted MRI (DWI) at admission (baseline) and 24 hours later (follow-up) and functional outcome at 90 days evaluated by the modified Rankin Scale (mRS). Methods: DWI infarct volumes were calculated, using an Analyze Software. Clinical outcomes were assessed at 90 days by the mRS. Univariate regression analysis was performed to assess the relationship between changes in DWI lesion volume and mRS less or equal to 1. Results: Sixty-nine cases had serial DWI scans with a measurable lesion at baseline and follow-up. The median baseline National Institutes of Health Stroke Scale (NIHSS) was 10, 5 and 7 at 24 hours. At 90 days, the proportion of patients with Rankin less or equal to 1 was 51.7%. The average baseline volume was 19.7 cm(3) and average follow-up volume was 46.1 cm(3). For each 10 cm(3) of growth in DWI infarct volume, the odds ratio for a mRS less or equal to 1 was 10,1 (IC 95%, 3-33.9). Conclusion: The results of this study provide evidence of a significant inverse relationship between infarct growth measured by DWI and good functional clinical outcome at 90 days. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 18 条
[1]   Baseline NIH Stroke Scale score strongly predicts outcome after stroke - A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) [J].
Adams, HP ;
Davis, PH ;
Leira, EC ;
Chang, KC ;
Bendixen, BH ;
Clarke, WR ;
Woolson, RF ;
Hansen, MD .
NEUROLOGY, 1999, 53 (01) :126-131
[2]   A three-item scale for the early prediction of stroke recovery [J].
Baird, AE ;
Dambrosia, J ;
Janket, SJ ;
Eichbaum, Q ;
Chaves, C ;
Silver, B ;
Barber, PA ;
Parsons, M ;
Darby, D ;
Davis, S ;
Caplan, LR ;
Edelman, RE ;
Warach, S .
LANCET, 2001, 357 (9274) :2095-2099
[3]   Change in Diffusion-Weighted Imaging Infarct Volume Predicts Neurologic Outcome at 90 Days Results of the Acute Stroke Accurate Prediction (ASAP) Trial Serial Imaging Substudy [J].
Barrett, Kevin M. ;
Ding, Yong Hong ;
Wagner, Douglas P. ;
Kallmes, David F. ;
Johnston, Karen C. .
STROKE, 2009, 40 (07) :2422-2427
[4]  
Beaulieu C, 1999, ANN NEUROL, V46, P568, DOI 10.1002/1531-8249(199910)46:4<568::AID-ANA4>3.0.CO
[5]  
2-R
[6]   Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial [J].
Bluhmki, Erich ;
Chamorro, Angel ;
Davalos, Antoni ;
Machnig, Thomas ;
Sauce, Christophe ;
Wahlgren, Nils ;
Wardlaw, Joanna ;
Hacke, Werner .
LANCET NEUROLOGY, 2009, 8 (12) :1095-1102
[7]   Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke [J].
Brown, DL ;
Johnston, KC ;
Wagner, DP ;
Haley, EC .
STROKE, 2004, 35 (01) :147-150
[8]   The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].
Hacke, W ;
Albers, G ;
Al-Rawi, Y ;
Bogousslavsky, J ;
Davalos, A ;
Eliasziw, M ;
Fischer, M ;
Furlan, A ;
Kaste, M ;
Lees, KR ;
Soehngen, M ;
Warach, S .
STROKE, 2005, 36 (01) :66-73
[9]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[10]   MR diffusion-weighted imaging and outcome prediction after ischemic stroke [J].
Hand, PJ ;
Wardlaw, JM ;
Rivers, CS ;
Armitage, PA ;
Bastin, ME ;
Lindley, RI ;
Dennis, MS .
NEUROLOGY, 2006, 66 (08) :1159-1163